Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 2,340.00
-5.00 (-0.21%)
Aug 11, 2026, 3:30 PM KST
Access Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 82,483 | 133,661 | 182,552 | 302,841 | 414,360 | 569,632 | |
Market Cap Growth | -56.49% | -26.78% | -39.72% | -26.91% | -27.26% | -27.38% |
Enterprise Value | -249,096 | -217,197 | -114,354 | -43,387 | -123,881 | 568,975 |
Last Close Price | 2345.00 | 3800.00 | 5190.00 | 8970.00 | 12200.00 | 14944.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 1.20 | 3.00 |
Forward PE | - | 22.67 | 22.67 | 22.67 | 22.67 | 22.67 |
PS Ratio | 5.52 | 4.28 | 1.62 | 0.87 | 0.40 | 1.13 |
PB Ratio | 0.14 | 0.24 | 0.28 | 0.52 | 0.66 | 1.96 |
P/TBV Ratio | 0.14 | 0.24 | 0.28 | 0.52 | 0.67 | 1.99 |
P/FCF Ratio | - | - | 10.23 | - | 1.18 | 4.40 |
P/OCF Ratio | - | - | 9.17 | - | 1.12 | 3.48 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | - | - | - | 1.13 |
EV/EBITDA Ratio | - | - | - | - | - | 2.14 |
EV/EBIT Ratio | - | - | - | - | - | 2.19 |
EV/FCF Ratio | - | - | - | - | - | 4.40 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.08 | 0.10 | 0.13 | 0.12 | 0.24 |
Debt / EBITDA Ratio | - | - | 8.83 | 1.93 | 0.16 | 0.26 |
Debt / FCF Ratio | - | - | 3.70 | - | 0.22 | 0.54 |
Net Debt / Equity Ratio | -0.58 | -0.64 | -0.60 | -0.47 | -0.68 | -0.45 |
Net Debt / EBITDA Ratio | 6.31 | 7.66 | -52.01 | -7.23 | -0.88 | -0.49 |
Net Debt / FCF Ratio | 4.65 | 11.63 | -21.78 | 2.24 | -1.21 | -1.01 |
Asset Turnover | 0.02 | 0.05 | 0.16 | 0.44 | 1.56 | 1.65 |
Inventory Turnover | 3.21 | 3.28 | 2.13 | 2.44 | 2.54 | 2.65 |
Quick Ratio | 15.31 | 16.37 | 11.49 | 8.38 | 3.01 | 1.85 |
Current Ratio | 16.86 | 17.42 | 12.38 | 9.51 | 3.65 | 2.37 |
Return on Equity (ROE) | -13.81% | -13.72% | -0.17% | -0.87% | 76.35% | 100.91% |
Return on Assets (ROA) | -6.27% | -5.95% | -1.10% | 1.74% | 44.09% | 53.02% |
Return on Invested Capital (ROIC) | -30.78% | -27.80% | -4.37% | 8.49% | 194.80% | 157.96% |
Return on Capital Employed (ROCE) | -11.30% | -11.00% | -1.80% | 3.40% | 67.90% | 85.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -100.83% | -61.44% | -0.19% | -1.05% | 83.66% | 33.30% |
FCF Yield | -86.79% | -23.17% | 9.78% | -40.45% | 84.58% | 22.72% |
Buyback Yield / Dilution | -38.67% | -41.84% | 26.52% | 10.73% | -1.46% | -7.75% |